Zim Laboratories Ltd
Zim Laboratories Ltd Share Price Today: Live Updates & Key Insights
Get insights on Zim Laboratories Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Zim Laboratories Ltd Share Price Chart
ZIMLAB at 10 Jul 2026 05:25 PM Pharmaceuticals
113.62 -2.31(-1.99%)
Lowest Today 113.62
Highest Today 113.92
Today's Open 0.00
Prev. Close 115.93
52 Week High 133.90
52 Week Low 59.31
Zim Laboratories Ltd Fundamentals
Traded Volume: 165
Market Cap(Cr): 608.42
Avg Traded Price 113.85
1 Year return -2.05%
Upper Circuit 113.9
Lower Circuit 113.6
P/E TTM 104.00
P/B Ratio 2.094
Traded Value(Cr) 0.19
EPS TTM 1.090
Book value/Share 55.360
Dividend Yield 1Y 0.00%
Zim Laboratories Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Zim Laboratories Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Zim Laboratories Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -8.74%
1M +0.50%
3M +58.93%
1Y -2.05%
YTD +64.74%
Zim Laboratories Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Zim Laboratories Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 9043.00
Day Before Yesterday 7715.00
1W Avg 15638.20
1M Avg 80079.00
3M Avg 93416.54
Zim Laboratories Ltd Technical Details
Zim Laboratories Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 116
Support 2 116
Support 3 116
Pivot Point : 116
Resistance 1 116
Resistance 2 116
Resistance 3 116
Zim Laboratories Ltd Corporate Actions
Zim Laboratories Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Zim Laboratories Ltd’s capital allocation strategies.
All
Ex-Date 22-Dec-2022 Type B Description share@2:1 Record Date 22-Dec-2022 Ratio 2:1
Ex-Date 19-Sep-2019 Type D Description 0.50/share@5.00% Record Date - Ratio 5.00
Ex-Date 04-Oct-2018 Type B Description share@1:1 Record Date 06-Oct-2018 Ratio 1:1
Ex-Date 03-Sep-2018 Type D Description 1.00/share@10.00% Record Date 04-Sep-2018 Ratio 10.00
Dividends
Announcement Date 19-Sep-2019 Ex Dividend Date 19-Sep-2019 Dividend(%) 5
Announcement Date 03-Sep-2018 Ex Dividend Date 03-Sep-2018 Dividend(%) 10
Bonus
Record Date 22-Dec-2022 Ex-Bonus Date 22-Dec-2022 Ratio 2:1
Record Date 06-Oct-2018 Ex-Bonus Date 04-Oct-2018 Ratio 1:1
Splits
No Split has been declared by ZIMLAB
Others
Rights No Rights has been declared by ZIMLAB
Zim Laboratories Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Zim Laboratories Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Zim Laboratories Ltd's relative performance and valuation against major competitors.
Stock Name Amanta Healthcare Ltd ₹179.17 (-2.00%) M. Cap (Cr) 6.96 1 Yr Return (%) NaN% P/E (TTM) 46.77 PB Ratio 3.16
Stock Name Influx Healthtech Ltd ₹289.00 (-0.65%) M. Cap (Cr) 6.69 1 Yr Return (%) NaN% P/E (TTM) 32.57 PB Ratio 6.64
Stock Name Kilitch Drugs (India) Ltd ₹183.10 (-0.62%) M. Cap (Cr) 6.40 1 Yr Return (%) -11.16% P/E (TTM) 21.22 PB Ratio 2.29
Stock Name Zim Laboratories Ltd ₹113.62 (-1.99%) M. Cap (Cr) 6.08 1 Yr Return (%) -2.05% P/E (TTM) 104.22 PB Ratio 2.05
Stock Name Jenburkt Pharmaceuticals Ltd ₹1114.80 (+1.23%) M. Cap (Cr) 4.92 1 Yr Return (%) -18.17% P/E (TTM) 14.16 PB Ratio 2.50
Stock Name Bafna Pharmaceuticals Ltd ₹204.61 (+2.00%) M. Cap (Cr) 4.84 1 Yr Return (%) +140.32% P/E (TTM) 43.61 PB Ratio 5.03
Stock Name Haleos Labs Limited ₹1596.60 (+3.22%) M. Cap (Cr) 4.83 1 Yr Return (%) +31.82% P/E (TTM) 27.88 PB Ratio 2.26
Zim Laboratories Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Zim Laboratories Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 47.66 Mar 2025 50.60 Mar 2024 11.47 Mar 2023 35.23 Mar 2022 47.03
PARTICULARS Investing Activities Mar 2026 -57.41 Mar 2025 -41.31 Mar 2024 -71.94 Mar 2023 -35.21 Mar 2022 -14.42
PARTICULARS Financing Activities Mar 2026 28.19 Mar 2025 -9.10 Mar 2024 59.53 Mar 2023 0.55 Mar 2022 -32.97
PARTICULARS Net Cash Flow Mar 2026 18.43 Mar 2025 0.19 Mar 2024 -0.94 Mar 2023 0.57 Mar 2022 -0.36
Zim Laboratories Ltd Shareholding Pattern
This shows the ownership breakdown of Zim Laboratories Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 30.35%
Public 69.57%
Other Institutions 0.07%
FII N/A%
Mutual Funds N/A%
About Zim Laboratories Ltd
Zim Laboratories Limited was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in Maharashtra. The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Mumbai. The Company commenced its operations in 1989 and is a specialist firm focused on the developing, manufacturing, and global distribution of differentiated generic Pharmaceutical and Nutraceutical products in oral solid dosage forms. The Company's comprehensive services include both PreFormulation Intermediates (PFI) and Finished Formulations (FF) across numerous vital therapeutic areas globally.Company's core therapeutic focus areas include: Urology, Gastrointestinal, NSAIDs / Analgesics, Anti-infectives, Cardiovascular, Central Nervous System, and Vitamins & Supplements. ZIM acts as a key supplier of both finished and semi-finished products within its targeted markets. ZIM operates three state-of-the-art manufacturing facilities i.e. General, Cephalosporin, and OTF and a well-established R&D centre, all staffed by highly skilled professionals. During the year 2019-20, ZIM Health Technologies Limited was acquired, making it a wholly owned subsidiary of the Company. SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia.In 2023, the Company launched Thinoral (Patented Oral Thin Film technology) as an alternate drug delivery platform across RoW/Pharmerging Markets and EU. The Company entered into a joint venture with an Australian marketing company to launch New Innovative Products (NIP) and Oral Thin Films (OTF) in 2025. The OTF business marked a milestone with its first commercial order supplied in Europe for Sildenafil citrate 50 milligram ODS. The product was launched in Italy and Malta in 2025.During FY26, ZIM completed a total of 57 regulatory filings across key geographies, comprising 14 NIP filings, 29 OTF filings, and 14 FF filings. In line with the global expansion strategy, ZIM entered into strategic collaborations, including a partnership with a local UAE company to scale our Oral Thin Films (OTF) footprint across the GCC region during the year 2026.
Chairman & Non Executive Dir.
Anwar Daud
Registered office Sadoday Gyan (Gr Floor), Opp NADT Nelson Square, Nagpur, Maharashtra, 440013
FAX :91-712-2588070
Background
Incorporation Year 1984
Face Value ₹10.00
Market Lot 1
FAQs on Zim Laboratories Ltd
How to buy Zim Laboratories Ltd shares?
To buy Zim Laboratories Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Zim Laboratories Ltd?
The company has a market capitalization of ₹608.42.
What is the PE & PB ratio of Zim Laboratories Ltd?
PE is 104 and PB is 2.094.
What is the Zim Laboratories Ltd dividend for 2025–26?
For the 2025–26 financial year, Zim Laboratories Ltd declared a final dividend of 0.00% per share.